Novartis Scores Its First Tumor-Agnostic Label For Two Nearly Decade-Old Cancer Drugs

 
• By Alaric DeArment
  
Novartis is the latest company to win FDA approval in a tumor-agnostic cancer indication • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip